ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BIOG Biotech Growth Trust (the) Plc

1,006.00
35.00 (3.60%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Biotech Growth Trust (the) Plc LSE:BIOG London Ordinary Share GB0000385517 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  35.00 3.60% 1,006.00 995.00 1,006.00 1,006.00 984.00 989.00 97,810 16:35:06
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Unit Inv Tr, Closed-end Mgmt -32.42M -41.3M -1.0034 -10.01 413.23M

The Biotech Growth Trust Plc - Issue of Equity

07/08/2020 5:30pm

PR Newswire (US)


Biotech Growth (LSE:BIOG)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Biotech Growth Charts.

THE BIOTECH GROWTH TRUST PLC

7 August 2020
 

Allotment of Ordinary Shares
 

THE BIOTECH GROWTH TRUST PLC (the “Company”) announces the allotment of 90,000 Ordinary shares of 25p each fully paid from its block listing authority. 

These shares were issued today at a price of 1269.75 pence per Ordinary share, which equates to a premium to the estimated  cum income net asset value per Ordinary share at the time of transaction of 1.0%  The cum income net asset value per Ordinary share at the close of business on 6 August 2020 was 1240.49 pence.

Following this issue, the Company has the ability to issue a further 5,648,134 Ordinary shares its block listing facility.

Following this transaction the Company hereby notifies the market that it has in issue 39,617,269 Ordinary shares of 25p each all with voting rights.  No shares were held in treasury at the date of announcement.

The figure of 39,617,269 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.



Enquiries:

Mark Pope                 
Frostrow Capital LLP            
Tel: 020 3 008 4913
 

Copyright st 7 PR Newswire

1 Year Biotech Growth Chart

1 Year Biotech Growth Chart

1 Month Biotech Growth Chart

1 Month Biotech Growth Chart

Your Recent History

Delayed Upgrade Clock